Cormedix Stock Price on December 21, 2024
| CRMD Stock | USD 8.57 0.30 3.38% |
Below is the normalized historical share price chart for CorMedix extending back to May 13, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CorMedix stands at 8.57, as last reported on the 22nd of December, with the highest price reaching 8.95 and the lowest price hitting 8.51 during the day.
If you're considering investing in CorMedix Stock, it is important to understand the factors that can impact its price. CorMedix appears to be somewhat reliable, given 3 months investment horizon. CorMedix secures Sharpe Ratio (or Efficiency) of 0.0773, which signifies that the company had a 0.0773% return per unit of risk over the last 3 months. We have found thirty technical indicators for CorMedix, which you can use to evaluate the volatility of the firm. Please makes use of CorMedix's Downside Deviation of 5.42, risk adjusted performance of 0.0793, and Mean Deviation of 3.29 to double-check if our risk estimates are consistent with your expectations.
At present, CorMedix's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 86.2 M, whereas Common Stock Total Equity is forecasted to decline to about 36.2 K. . At present, CorMedix's Price To Book Ratio is projected to slightly grow based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 2.87, whereas Price Earnings Ratio is forecasted to decline to (4.34). CorMedix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of March 2010 | 200 Day MA 6.5714 | 50 Day MA 10.3498 | Beta 1.582 |
CorMedix |
Sharpe Ratio = 0.0773
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.66 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average CorMedix is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CorMedix by adding it to a well-diversified portfolio.
Price Book 8.8568 | Enterprise Value Ebitda (3.50) | Price Sales 42.4069 | Shares Float 60.1 M | Wall Street Target Price 16.25 |
CorMedix Valuation on December 21, 2024
It is possible to determine the worth of CorMedix on a given historical date. On December 21, 2024 CorMedix was worth 8.66 at the beginning of the trading date compared to the closed value of 8.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CorMedix stock. Still, in general, we apply an absolute valuation method to find CorMedix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CorMedix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CorMedix's related companies.
| Open | High | Low | Close | Volume | |
| 8.44 | 9.02 | 8.29 | 8.87 | 1,141,034 | |
12/20/2024 | 8.66 | 8.95 | 8.51 | 8.57 | 2,460,823 |
| 8.66 | 8.95 | 8.51 | 8.57 | 0.00 |
| Backtest CorMedix | | | CorMedix History | | | CorMedix Valuation | Previous | Next |
CorMedix Trading Date Momentum on December 21, 2024
| On December 22 2024 CorMedix was traded for 8.57 at the closing time. The top price for the day was 8.95 and the lowest listed price was 8.51 . There was no trading activity during the period 0.0. Lack of trading volume on December 22, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.05% . |
CorMedix Fundamentals Correlations and Trends
By evaluating CorMedix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CorMedix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CorMedix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CorMedix Stock history
CorMedix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CorMedix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CorMedix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CorMedix stock prices may prove useful in developing a viable investing in CorMedix
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 50.9 M | 53.4 M | |
| Net Loss | -26.7 M | -28.1 M |
CorMedix Quarterly Net Working Capital |
|
CorMedix Stock Technical Analysis
CorMedix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CorMedix Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
CorMedix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CorMedix December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how CorMedix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CorMedix shares will generate the highest return on investment. By undertsting and applying CorMedix stock market strength indicators, traders can identify CorMedix entry and exit signals to maximize returns
CorMedix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CorMedix's price direction in advance. Along with the technical and fundamental analysis of CorMedix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CorMedix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0793 | |||
| Jensen Alpha | 0.382 | |||
| Total Risk Alpha | 0.2777 | |||
| Sortino Ratio | 0.0713 | |||
| Treynor Ratio | 0.3426 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |